Our | Products


BINAP®





THERAPEUTIC AREA: Onco-Hematology
ACTIVE PRINCIPLE: Ibrutinib
PRESENTATION: 90 y 120 capsules of 140mg
INDICATION:

  • Chronic lymphocytic leukemia (CLL)
  • Mantle cell lymphoma (MCL)
  • Waldenström's macroglobulinemia (WM)

COUNTRIES WHERE IT IS MARKETED:
Argentina Ecuador Perú